News | 08 August 2012
Dublin-based speciality pharmaceuticals group Warner Chilcott plc (NASDAQ:WCRX) said it had terminated talks with potential buyers and decided instead to pursue other alternatives to boost shareholder value. At the end of its review of strategic ...
Click on the link to read the full article at FinancialNews.co.uk
(This link will open in a new window)